These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38861833)

  • 1. Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression.
    Gu X; Zhu Y; Su J; Wang S; Su X; Ding X; Jiang L; Fei X; Zhang W
    Redox Biol; 2024 Aug; 74():103209. PubMed ID: 38861833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis.
    Pradhan R; Paul S; Acharya SS; Sinha S; Dash SR; Kundu CN
    J Nutr Biochem; 2024 Mar; 125():109568. PubMed ID: 38185347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
    Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
    Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinesin 26B modulates M2 polarization of macrophage by activating cancer-associated fibroblasts to aggravate gastric cancer occurrence and metastasis.
    Huang LM; Zhang MJ
    World J Gastroenterol; 2024 May; 30(20):2689-2708. PubMed ID: 38855156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
    Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Integrative Analysis Reveals the Association of
    Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts.
    Shimizu D; Yuge R; Kitadai Y; Ariyoshi M; Miyamoto R; Hiyama Y; Takigawa H; Urabe Y; Oka S
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma.
    Zhang A; Qian Y; Ye Z; Chen H; Xie H; Zhou L; Shen Y; Zheng S
    Cancer Med; 2017 Feb; 6(2):463-470. PubMed ID: 28097809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
    Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
    Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling.
    Ren Y; Cao L; Wang L; Zheng S; Zhang Q; Guo X; Li X; Chen M; Wu X; Furlong F; Meng Z; Xu K
    Cell Death Dis; 2021 Sep; 12(10):858. PubMed ID: 34552063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad3 Promotes Cancer-Associated Fibroblasts Generation via Macrophage-Myofibroblast Transition.
    Tang PC; Chung JY; Xue VW; Xiao J; Meng XM; Huang XR; Zhou S; Chan AS; Tsang AC; Cheng AS; Lee TL; Leung KT; Lam EW; To KF; Tang PM; Lan HY
    Adv Sci (Weinh); 2022 Jan; 9(1):e2101235. PubMed ID: 34791825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CPT1C-positive cancer-associated fibroblast facilitates immunosuppression through promoting IL-6-induced M2-like phenotype of macrophage.
    Wei R; Song J; Pan H; Liu X; Gao J
    Oncoimmunology; 2024; 13(1):2352179. PubMed ID: 38746869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts-derived exosomes promote lung cancer progression by OIP5-AS1/ miR-142-5p/ PD-L1 axis.
    Jiang Y; Wang K; Lu X; Wang Y; Chen J
    Mol Immunol; 2021 Dec; 140():47-58. PubMed ID: 34653794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD248-expressing cancer-associated fibroblasts induce epithelial-mesenchymal transition of non-small cell lung cancer via inducing M2-polarized macrophages.
    Xiao J; Yang Z; Wang S; Liu X; Wang Y; Hu Z; Zeng Z; Wu J
    Sci Rep; 2024 Jun; 14(1):14343. PubMed ID: 38906929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer.
    Zhang R; Qi F; Zhao F; Li G; Shao S; Zhang X; Yuan L; Feng Y
    Cell Death Dis; 2019 Mar; 10(4):273. PubMed ID: 30894509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade.
    Owaki T; Iida T; Miyai Y; Kato K; Hase T; Ishii M; Ando R; Hinohara K; Akashi T; Mizutani Y; Ishikawa T; Mii S; Shiraki Y; Esaki N; Yamamoto M; Tsukamoto T; Nomura S; Murakami T; Takahashi M; Yuguchi Y; Maeda M; Sano T; Sassa N; Matsukawa Y; Kawashima H; Akamatsu S; Enomoto A
    Br J Cancer; 2024 Jul; 131(2):372-386. PubMed ID: 38849479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma.
    Suzuki J; Aokage K; Neri S; Sakai T; Hashimoto H; Su Y; Yamazaki S; Nakamura H; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Tsuboi M; Ishii G
    Lung Cancer; 2021 Mar; 153():1-10. PubMed ID: 33429158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD
    Yang M; Wang B; Hou W; Zeng H; He W; Zhang XK; Yan D; Yu H; Huang L; Pei L; Li K; Qin H; Lin T; Huang J
    J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 39067875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.